← Eichor
Condition: Ondansetron Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Ondansetron

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section
NA · 1 location(s) · Tanta University · NCT07511491Ondansetron Use for Preventing Pruritus in Patients Undergoing Cesarean Section
Phase 1 · 1 location(s) · Wayne State University · NCT06297499Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan
Phase 3 · 1 location(s) · Augusta University · NCT06588413Antiemetic Fosaprepitant To Remedy Nausea and Vomiting
Phase 2/Phase 3 · 1 location(s) · Montefiore Medical Center · NCT06382012Ondansetron for the Management of Atrial Fibrillation
Phase 4 · 3 location(s) · Indiana University · NCT05844501Intravenous Versus Perineural Ondansetron for Laparoscopic Sleeve Gastrectomy
NA · 1 location(s) · Tanta University · NCT06810882Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk f
Phase 2 · 1 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06887621Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatograp
Phase 3 · 1 location(s) · Tanta University · NCT06861010Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Tonsillectomy
NA · 1 location(s) · Tanta University · NCT07489742Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paedia
Phase 2 · 20 location(s) · Helsinn Healthcare SA · NCT06904235Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin
Phase 2 · 1 location(s) · Mahidol University · NCT07699276BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron
Phase 4 · 1 location(s) · University of Illinois at Chicago · NCT04150614Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy
Phase 4 · 1 location(s) · Chongqing University Cancer Hospital · NCT07217600Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia
Phase 2 · 1 location(s) · Mayo Clinic · NCT03865290Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compar
Phase 3 · 1 location(s) · Yizhuo Zhang · NCT06208917Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy
Phase 3 · 1 location(s) · Mahidol University · NCT06850454A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Tr
Phase 2 · 1 location(s) · University of Calgary · NCT05755737
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.